<DOC>
	<DOCNO>NCT02549053</DOCNO>
	<brief_summary>The aim study determine whether prevalence Human PapillomaVirus ( HPV ) increase patient Barrett esophagus compare control prospective study . Secondary objective identify , present , type Human PapillomaVirus ( HPV ) associate Barrett esophagus .</brief_summary>
	<brief_title>Prevalence Human Papillomavirus Barrett Esophagus Compared With Controls</brief_title>
	<detailed_description>Barrett 's esophagus ( BE ) define replacement normal stratify squamous epithelium distal third esophagus specialize intestinal metaplasia . It relate gastro-esophageal reflux disease . Diagnosis suspect endoscopy confirm biopsy . The classification CM Prague validate describe BE endoscopy . The main complication BE adenocarcinoma , accord metaplasia-dysplasia-cancer sequence . The incidence esophageal adenocarcinoma variable , range 0.4 3 % . BE find 100 % esophageal adenocarcinoma 42 % junction adenocarcinoma . Among unknown risk factor involve onset dysplasia , virus ca n't exclude . It well establish Human Papillomavirus ( HPV ) strongly associate squamous cell dysplasia female uterine cervix progression cervical carcinoma . HPV also implicate others invasive carcinoma include uterine cervix , vulvar , vaginal , anal , penile , head neck squamous cell carcinoma . Several study show HPV could associate head neck cancer tumor HPV status patient oropharyngeal squamous cell carcinoma independent prognostic factor survival . The association HPV esophageal squamous cell carcinoma still controversed epidemiological study report prevalence mucosal HPV DNA range 0 70 % . Studies investigate HPV adenocarcinoma esophagus Barrett 's esophagus ( BE ) scarce data clear . A recent prospective study show HPV strongly associate Barrett'dysplasia esophageal adenocarcinoma . The aim study determine whether prevalence HPV increase patient BE compare control prospective study . Secondary objective identify , present , type HPV associate BE .</detailed_description>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>write consent obtain gastroscopy , patient age 18 year , normal coagulation parameter Inclusion criterion group A `` control '' B `` BE '' follow , respectively : patient undergo gastroscopy non esophageal reason present clinical , endoscopic histopathological evidence GERD complication patient undergoing gastroscopy BE surveillance suspect BE gastroscopy . write consent obtain gastroscopy , inability give inform consent , pregnant nursing woman , major person protect french law , person affiliate social security regime , patient exclusion period another clinical study , curative anticoagulation treatment , hemostatic disturbance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>